611 related articles for article (PubMed ID: 29756399)
1. Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients.
Du G; Lewis MM; Sica C; He L; Connor JR; Kong L; Mailman RB; Huang X
Mov Disord; 2018 Sep; 33(9):1423-1431. PubMed ID: 29756399
[TBL] [Abstract][Full Text] [Related]
2. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
[TBL] [Abstract][Full Text] [Related]
3. Increased iron in the substantia nigra pars compacta identifies patients with early Parkinson'sdisease: A 3T and 7T MRI study.
Alushaj E; Handfield-Jones N; Kuurstra A; Morava A; Menon RS; Owen AM; Sharma M; Khan AR; MacDonald PA
Neuroimage Clin; 2024; 41():103577. PubMed ID: 38377722
[TBL] [Abstract][Full Text] [Related]
4. Quantitative assessment of iron deposition in the midbrain using 3D-enhanced T2 star weighted angiography (ESWAN): a preliminary cross-sectional study of 20 Parkinson's disease patients.
Wang C; Fan G; Xu K; Wang S
Magn Reson Imaging; 2013 Sep; 31(7):1068-73. PubMed ID: 23746648
[TBL] [Abstract][Full Text] [Related]
5. Quantitative susceptibility mapping of the midbrain in Parkinson's disease.
Du G; Liu T; Lewis MM; Kong L; Wang Y; Connor J; Mailman RB; Huang X
Mov Disord; 2016 Mar; 31(3):317-24. PubMed ID: 26362242
[TBL] [Abstract][Full Text] [Related]
6. Increased iron-deposition in lateral-ventral substantia nigra pars compacta: A promising neuroimaging marker for Parkinson's disease.
He N; Langley J; Huddleston DE; Chen S; Huang P; Ling H; Yan F; Hu X
Neuroimage Clin; 2020; 28():102391. PubMed ID: 32889398
[TBL] [Abstract][Full Text] [Related]
7. Neuromelanin-sensitive magnetic resonance imaging features of the substantia nigra and locus coeruleus in de novo Parkinson's disease and its phenotypes.
Wang J; Li Y; Huang Z; Wan W; Zhang Y; Wang C; Cheng X; Ye F; Liu K; Fei G; Zeng M; Jin L
Eur J Neurol; 2018 Jul; 25(7):949-e73. PubMed ID: 29520900
[TBL] [Abstract][Full Text] [Related]
8. Iron deposition in Parkinson's disease by quantitative susceptibility mapping.
Chen Q; Chen Y; Zhang Y; Wang F; Yu H; Zhang C; Jiang Z; Luo W
BMC Neurosci; 2019 May; 20(1):23. PubMed ID: 31117957
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Susceptibility Mapping in Parkinson's Disease.
Langkammer C; Pirpamer L; Seiler S; Deistung A; Schweser F; Franthal S; Homayoon N; Katschnig-Winter P; Koegl-Wallner M; Pendl T; Stoegerer EM; Wenzel K; Fazekas F; Ropele S; Reichenbach JR; Schmidt R; Schwingenschuh P
PLoS One; 2016; 11(9):e0162460. PubMed ID: 27598250
[TBL] [Abstract][Full Text] [Related]
10. 7 Tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson's disease.
Lehéricy S; Bardinet E; Poupon C; Vidailhet M; François C
Mov Disord; 2014 Nov; 29(13):1574-81. PubMed ID: 25308960
[TBL] [Abstract][Full Text] [Related]
11. Parkinson's disease related signal change in the nigrosomes 1-5 and the substantia nigra using T2* weighted 7T MRI.
Schwarz ST; Mougin O; Xing Y; Blazejewska A; Bajaj N; Auer DP; Gowland P
Neuroimage Clin; 2018; 19():683-689. PubMed ID: 29872633
[TBL] [Abstract][Full Text] [Related]
12. Association of freezing of gait with nigral iron accumulation in patients with Parkinson's disease.
Naduthota RM; Honnedevasthana AA; Lenka A; Saini J; Geethanath S; Bharath RD; Christopher R; Yadav R; Gupta AK; Pal PK
J Neurol Sci; 2017 Nov; 382():61-65. PubMed ID: 29111022
[TBL] [Abstract][Full Text] [Related]
13. Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping.
Guan X; Xuan M; Gu Q; Huang P; Liu C; Wang N; Xu X; Luo W; Zhang M
NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 26853890
[TBL] [Abstract][Full Text] [Related]
14. In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson's disease using neuromelanin-sensitive MRI: Replication in two cohorts.
Hwang KS; Langley J; Tripathi R; Hu XP; Huddleston DE
PLoS One; 2023; 18(4):e0282684. PubMed ID: 37053195
[TBL] [Abstract][Full Text] [Related]
15. Short-echo-time magnitude image derived from quantitative susceptibility mapping could resemble neuromelanin-sensitive MRI image in substantia nigra.
Liu XL; Yang LQ; Liu FT; Wu PY; Zhang Y; Zhuang H; Shi YH; Wang J; Geng DY; Li YX
BMC Neurol; 2020 Jun; 20(1):262. PubMed ID: 32605601
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility Magnetic Resonance Imaging Correlates with Glial Density and Tau in the Substantia Nigra Pars Compacta.
Wang EW; Brown GL; Lewis MM; Jellen LC; Pu C; Johnson ML; Chen H; Kong L; Du G; Huang X
Mov Disord; 2023 Mar; 38(3):464-473. PubMed ID: 36598274
[TBL] [Abstract][Full Text] [Related]
17. A preliminary attempt to visualize nigrosome 1 in the substantia nigra for Parkinson's disease at 3T: An efficient susceptibility map-weighted imaging (SMWI) with quantitative susceptibility mapping using deep neural network (QSMnet).
Jo M; Oh SH
Med Phys; 2020 Mar; 47(3):1151-1160. PubMed ID: 31883389
[TBL] [Abstract][Full Text] [Related]
18. Ventral posterior substantia nigra iron increases over 3 years in Parkinson's disease.
Bergsland N; Zivadinov R; Schweser F; Hagemeier J; Lichter D; Guttuso T
Mov Disord; 2019 Jul; 34(7):1006-1013. PubMed ID: 31180615
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive MRI quantification of the substantia nigra pars compacta in Parkinson's disease.
Takahashi H; Watanabe Y; Tanaka H; Mihara M; Mochizuki H; Takahashi K; Yamamoto K; Liu T; Wang Y; Tomiyama N
Eur J Radiol; 2018 Dec; 109():48-56. PubMed ID: 30527311
[TBL] [Abstract][Full Text] [Related]
20. Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2.
Barbosa JH; Santos AC; Tumas V; Liu M; Zheng W; Haacke EM; Salmon CE
Magn Reson Imaging; 2015 Jun; 33(5):559-65. PubMed ID: 25721997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
